AC
TMO icon

Arjuna Capital’s Thermo Fisher Scientific TMO Stock Holding History

Arjuna Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Sell
6,210
-373
-6% -$202K 0.78% 35
2025
Q4 		$3.81M Buy
6,583
+2,582
+65% +$1.46M 0.93% 24
2025
Q3 		$1.94M Sell
4,001
-4,188
-51% -$1.95M 0.48% 52
2025
Q2 		$3.32M Sell
8,189
-2,164
-21% -$905K 0.88% 26
2025
Q1 		$5.15M Sell
10,353
-6,531
-39% -$3.54M 1.43% 14
2024
Q4 		$8.78M Buy
16,884
+392
+2% +$216K 2.34% 10
2024
Q3 		$10.2M Sell
16,492
-125
-0.8% -$74K 2.64% 6
2024
Q2 		$9.19M Buy
16,617
+2,457
+17% +$1.41M 2.47% 7
2024
Q1 		$8.23M Buy
14,160
+592
+4% +$332K 2.33% 9
2023
Q4 		$7.2M Buy
13,568
+732
+6% +$354K 2.25% 10
2023
Q3 		$6.5M Buy
12,836
+485
+4% +$258K 2.33% 8
2023
Q2 		$6.44M Buy
12,351
+490
+4% +$264K 2.28% 7
2023
Q1 		$6.84M Sell
11,861
-478
-4% -$269K 2.68% 5
2022
Q4 		$6.79M Buy
12,339
+294
+2% +$156K 3.13% 6
2022
Q3 		$6.11M Buy
12,045
+39
+0.3% +$21.8K 3% 5
2022
Q2 		$6.52M Buy
12,006
+242
+2% +$133K 3.16% 5
2022
Q1 		$6.95M Buy
11,764
+379
+3% +$218K 2.9% 6
2021
Q4 		$7.6M Buy
11,385
+565
+5% +$353K 2.78% 9
2021
Q3 		$6.18M Buy
10,820
+470
+5% +$258K 2.51% 9
2021
Q2 		$5.22M Buy
10,350
+740
+8% +$349K 2.26% 9
2021
Q1 		$4.39M Buy
9,610
+574
+6% +$274K 2.16% 12
2020
Q4 		$4.21M Buy
9,036
+317
+4% +$149K 2.33% 8
2020
Q3 		$3.85M Buy
8,719
+1,746
+25% +$721K 2.39% 11
2020
Q2 		$2.53M Buy
6,973
+85
+1% +$28.5K 1.74% 15
2020
Q1 		$1.95M Buy
6,888
+227
+3% +$71.6K 1.63% 21
2019
Q4 		$2.16M Buy
6,661
+168
+3% +$50.9K 1.57% 22
2019
Q3 		$1.89M Buy
6,493
+144
+2% +$41.2K 1.61% 26
2019
Q2 		$1.86M Buy
6,349
+485
+8% +$134K 1.34% 28
2019
Q1 		$1.6M Buy
5,864
+3,106
+113% +$773K 1.24% 28
2018
Q4 		$617K Sell
2,758
-1
-0% -$235 0.56% 54
2018
Q3 		$673K Buy
+2,759
New +$635K 0.51% 58

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arjuna Capital's TMO Position: Q1 2026 in Review

Arjuna Capital reduced its Thermo Fisher Scientific (TMO) stake by 5.7% in Q1 2026, selling an estimated $202K and leaving 6,210 shares worth $3.05M. The position accounts for 0.78% of the portfolio, ranked #35.

Arjuna Capital first reported a position in TMO in Q3 2018 and has held it in 31 quarters since. The position peaked at $10.2M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Arjuna Capital held 6,210 shares of Thermo Fisher Scientific worth $3.05M as of Q1 2026.
  • Arjuna Capital sold 373 Thermo Fisher Scientific shares in Q1 2026, an estimated $202K.
  • Thermo Fisher Scientific made up 0.78% of Arjuna Capital's portfolio in Q1 2026, its #35 holding.
  • Arjuna Capital first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 31 quarters since.
  • Arjuna Capital's Thermo Fisher Scientific position peaked at $10.2M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Arjuna Capital's 13F filing for Q1 2026, filed 6 May 2026.